Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:55.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a condition reference and linked the Genetic and Rare Diseases Information Center under Resources; updated the page revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T19:40:21.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:30.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page shows a new footer revision 'Revision: v3.4.2' and removes the government funding status notice (formerly 'Revision: v3.4.1'). This appears to be a routine site maintenance update with no effect on the study content or results.
    Difference
    0.4%
    Check dated 2026-02-11T05:07:20.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    A global banner about government funding and NIH operations was added, with links to cc.nih.gov and opm.gov, and the site revision updated to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T03:45:52.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    UI and metadata updates: a glossary display option was added, and the study history now includes 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:18:36.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.